2019 Annual Meeting of the American Association for the Study of Liver Diseases*

Download All
November 8-12, 2019; Boston, Massachusetts
Download slides or audio and review Capsule Summaries on practice-changing viral hepatitis and NAFLD/NASH data from Boston.
Ira M. Jacobson, MD
Nancy Reau, MD
Norah Terrault Headshot
Norah Terrault, MD, MPH
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD

Highlights

Slidesets Patient-Centered HBV Educational Intervention Increased Knowledge and Improved HBV Monitoring and Management
Slidesets Reduced HCC Mortality With More Frequent Clinic Follow-up Among Patients With Chronic Hepatitis B in South Korea
Slidesets Low Risk of HCC After Spontaneous and NA-Induced HBsAg Seroclearance
Slidesets High Prevalence of HCV Among African Immigrants With HCC in Minnesota
Slidesets SWAP: Adding or Switching to PegIFN Improves Response in Patients With Chronic Hepatitis B on Long-Term NA Therapy
Slidesets Scoring Method to Identify Low HCC Risk in Patients With Advanced Fibrosis After SVR to HCV Therapy
Slidesets British Columbia Hepatitis Testers Cohort: HCV Reinfection Rate ~ 2/100 PY Following SVR With DAA Treatment Among Persons Who Inject Drugs
Slidesets Factors Associated With Mortality in US Adults With NAFLD
Slidesets REGENERATE: Obeticholic Acid Improves Liver Fibrosis in Expanded Analysis of Patients With NASH
Slidesets Short-Course Glecaprevir/Pibrentasvir Plus Ezetimibe Prevents HCV Transmission During Transplantation From HCV-Infected Donors

This downloadable slideset reviews new, clinically relevant data on viral hepatitis and NAFLD/NASH; topics include risk of HCC in patients with viral hepatitis, HBV and HCV treatment, organ transplant from donors with HCV infection, and novel treatments for NAFLD/NASH.

Ira M. Jacobson, MD Nancy Reau, MD Released: December 2, 2019

Listen to downloadable audio from a live Webinar reviewing the most clinically relevant new NAFLD/NASH data. Topics include global disease burden, treatments in development, and disease monitoring.

Zobair Younossi Headshot Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD Released: November 22, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on the most clinically relevant new viral hepatitis data presented at AASLD 2019, including updated information on HCV incidence and management and HBV management.

Norah Terrault Headshot Norah Terrault, MD, MPH Released: November 22, 2019
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings